Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gossamer Bio, Inc. | 58,050 | reported | 19 Aug 2025 | tx 7+400,050 |
| Organon & Co. | 28,599 | reported | 04 May 2023 | tx 41+695,776−52,983 |
| CIPHERGEN BIOSYSTEMS INC | 13,644 | reported | 08 Jan 2025 | tx 8+135,000−26,356 |
| Spyre Therapeutics, Inc. | 8,026 | reported | 27 May 2026 | tx 3+55,006 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 8,026 | 0.00 USD | deriv |
| 19 Aug 2025 | PURCHASE | Gossamer Bio, Inc. | 26,050 | 1.92 USD | first after silence |
| 25 Jun 2025 | GRANT_AWARD | Gossamer Bio, Inc. | 115,000 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | CIPHERGEN BIOSYSTEMS INC | 20,000 | 0.00 USD | |
| 31 Dec 2024 | EXERCISE | CIPHERGEN BIOSYSTEMS INC | 20,000 | 0.00 USD | deriv |
| 12 Nov 2024 | GRANT_AWARD | CIPHERGEN BIOSYSTEMS INC | 25,000 | 0.00 USD | deriv |
| 28 Oct 2024 | GRANT_AWARD | CIPHERGEN BIOSYSTEMS INC | 20,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Gossamer Bio, Inc. | 115,000 | 0.00 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 21,980 | 0.00 USD | deriv |
| 03 May 2024 | GRANT_AWARD | CIPHERGEN BIOSYSTEMS INC | 30,000 | 0.00 USD | deriv |
| 15 Nov 2023 | PURCHASE | Gossamer Bio, Inc. | 32,000 | 0.79 USD | |
| 08 Jun 2023 | GRANT_AWARD | Gossamer Bio, Inc. | 35,000 | 0.00 USD | deriv |
| 04 May 2023 | TAX_WITHHOLDING | Organon & Co. | 2,168 | 24.24 USD | |
| 04 May 2023 | EXERCISE | Organon & Co. | 4,984 | — | |
| 04 May 2023 | EXERCISE | Organon & Co. | 4,984 | 0.00 USD | deriv |
| 01 May 2023 | EXERCISE | Organon & Co. | 1,899 | — | |
| 01 May 2023 | TAX_WITHHOLDING | Organon & Co. | 826 | 24.63 USD | |
| 01 May 2023 | EXERCISE | Organon & Co. | 1,899 | 0.00 USD | deriv |
| 31 Mar 2023 | TAX_WITHHOLDING | Organon & Co. | 2,115 | 23.09 USD | |
| 31 Mar 2023 | EXERCISE | Organon & Co. | 5,964 | 0.00 USD | |
| 31 Mar 2023 | EXERCISE | Organon & Co. | 5,964 | 0.00 USD | deriv |
| 31 Mar 2023 | GRANT_AWARD | Organon & Co. | 29,230 | 0.00 USD | deriv |
| 31 Mar 2023 | GRANT_AWARD | Organon & Co. | 104,961 | 0.00 USD | deriv |
| 28 Feb 2023 | EXERCISE | Organon & Co. | 7,976 | — |
1 purchase reported after at least 12 months of silence — most recent on 19 Aug 2025.